Attenuated arterial baroreflex buffering of muscle metaboreflex in heart failure

Jong-Kyung Kim1, Javier A Sala-Mercado, Robert L Hammond

  • 1Dept. of Physiology, Wayne State Univ. School of Medicine, 540 East Canfield Ave., Detroit, MI 48201, USA.

Insights

Sinoaortic denervation (SAD) enhances muscle metaboreflex responses by increasing peripheral vasoconstriction. In heart failure (HF), SAD does not significantly alter these responses, suggesting impaired baroreflex buffering in HF.

Area of Science:

  • Cardiovascular Physiology
  • Exercise Physiology
  • Autonomic Nervous System Regulation

Background:

  • Heart failure (HF) and sinoaortic denervation (SAD) are known to alter muscle metaboreflex function during exercise.
  • The specific impact of SAD on the muscle metaboreflex in the context of HF remains unclear.

Purpose of the Study:

  • To quantify the roles of cardiac output (CO) and peripheral vasoconstriction in metaboreflex-mediated mean arterial blood pressure (MAP) increases.
  • To investigate the effects of SAD on the muscle metaboreflex in both healthy and HF states during dynamic exercise.

Main Methods:

  • Utilized conscious, chronically instrumented dogs for experiments.
  • Induced HF and performed SAD to assess baroreflex and metaboreflex responses.
  • Activated the muscle metaboreflex by reducing hindlimb blood flow during mild and moderate exercise.

Main Results:

  • SAD significantly amplified pressor responses compared to barointact conditions, despite reduced CO.
  • In HF, SAD resulted in lower pressor responses than in SAD-alone conditions, but still higher than in HF barointact.
  • SAD induced significant peripheral vasoconstriction, unlike in barointact conditions where vascular conductance remained unchanged.

Conclusions:

  • SAD markedly enhances the contribution of peripheral vasoconstriction to exercise pressor responses.
  • In HF, SAD does not substantially change metaboreflex patterns, indicating impaired baroreflex buffering capacity.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...